www.fdanews.com/articles/196456-fda-creates-coronavirus-treatment-acceleration-program
FDA Creates Coronavirus Treatment Acceleration Program
March 31, 2020
The FDA launched the Coronavirus Treatment Acceleration Program (CTAP), an emergency program for potential COVID-19 therapies.
The agency has deployed staff specifically to reviewing COVID-19 therapies.
The agency is currently monitoring 10 therapies in active trials and 15 others in planning stages.
